Bio-Rad Laboratories (BIO) Free Cash Flow (2009 - 2026)

Bio-Rad Laboratories (BIO) has reported Free Cash Flow for 18 consecutive years, with $66.7 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Free Cash Flow fell 5.79% year-over-year to $66.7 million in Q2 2026; TTM through Jun 2026 was $353.1 million, a 4.82% decrease from a year earlier, with the FY2025 full-year figure at $374.6 million, up 29.35% from the prior year.
• Free Cash Flow was $66.7 million for Q2 2026 at Bio-Rad Laboratories, down from $78.1 million in the prior quarter.
• Over five years, Free Cash Flow peaked at $123.4 million in Q3 2024 and troughed at -$16.6 million in Q3 2022.
• A 5-year average of $61.6 million and a median of $62.9 million in 2023 frame the typical range for Free Cash Flow.
• Across the five-year window, Free Cash Flow tumbled 108.47% in 2022 and soared 423.55% in 2023, its largest moves.
• Over 5 years, Free Cash Flow stood at $44.8 million in 2022, then slipped by 13.51% to $38.7 million in 2023, then soared by 109.89% to $81.3 million in 2024, then surged by 46.49% to $119.1 million in 2025, then slumped by 44.0% to $66.7 million in 2026.
• The last three Free Cash Flow figures came in at $66.7 million (Q2 2026), $78.1 million (Q1 2026), and $119.1 million (Q4 2025), per Business Quant data.